Le Lézard
Classified in: Health
Subjects: POL, CFG

Government of Canada launches Advisory Council on the Implementation of National Pharmacare


Advisory Council begins consultations with Canadians on next steps in establishing a national pharmacare program

OTTAWA, June 20, 2018 /CNW/ - Canadians are proud of our publicly funded health care system, which is based on need and not on ability to pay. However, prescription drugs are not covered in a consistent way across the country, and too many Canadians cannot afford the medicines they need. A recent study found that almost one million Canadians reduced spending on food and heat in order to afford their medication.

In Budget 2018, the Government of Canada announced the creation of an Advisory Council on the Implementation of National Pharmacare, and appointed Dr. Eric Hoskins as the Chair of the Council.

Today, the Honourable Ginette Petitpas Taylor, Minister of Health, and the Honourable Bill Morneau, Minister of Finance, announced that the Government has appointed six accomplished Canadians as members of the Council. Chaired by Dr. Hoskins, the Council will include:

As part of its work, the Council will conduct a fiscal, economic and social assessment of domestic and international pharmacare models. It will also consult extensively with Canadians to hear and better understand their views on pharmacare.

To that end, over the next few months, the Council will travel across the country to meet with Canadians, health care experts, patients, interested stakeholders, and provincial, territorial, and Indigenous leaders.

In the next few weeks, Canadians will be invited to engage the Council by sharing their views through an online questionnaire and through written submissions. In the meantime, Canadians can read the discussion paper, which provides an overview of Canada's current system of prescription drug coverage and its challenges.   

The input received will help shape the Council's independent interim report, which will be delivered to the Minister of Health and the Minister of Finance later this year, followed by its final report in spring 2019. The report will provide the Government with recommendations on how to best move forward on implementing a national pharmacare program that meets the needs of, and is affordable for, Canadians, employers and governments.

Quotes

"I wish to thank the members of the Advisory Council on the Implementation of National Pharmacare for undertaking this very important task on behalf of Canadians. Improving access to prescription medications will help Canadians?especially those with no prescription drug coverage?to stay healthy. The work of the Advisory Council will be fundamental to ensuring that Canadians have access to the drug therapies they need at an affordable cost."

The Honourable Ginette Petitpas Taylor
Minister of Health

"Today, the Government of Canada is taking an important step toward ensuring that all Canadians can afford the prescription drugs they need. I look forward to receiving the recommendations of the Advisory Council, and to working with our partners to deliver a national pharmacare program that works for all Canadians."

The Honourable Bill Morneau
Minister of Finance

"Ensuring access to prescribed medications is vital from both a health equity and health outcome perspective. Too many Canadians are unable to maintain or achieve a healthy life because they cannot afford needed prescription drugs. I am both honoured and proud to lead this work, which I believe will result in a more equitable and sustainable health system, as well as better health outcomes, for all Canadians."

Dr. Eric Hoskins
Chair of the Advisory Council on the Implementation of National Pharmacare

Quick Facts

Associated Links

 

SOURCE Health Canada


These press releases may also interest you

at 08:30
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Sandra M. Swain, M.D., to its Board of Directors. Dr. Swain has over 30 years of oncology...

at 08:22
The Quest Diagnostics Foundation today announced an expanded collaboration with Green Bronx Machine (GBM), a transformational educational nonprofit...

at 08:07
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has released a comprehensive contract research organization (CRO) offering tailor-made for sponsors looking to bring diagnostic products...

at 08:05
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in a pilot study collecting patient-generated health data (PGHD) during proton radiotherapy for lung cancer in...

at 08:05
Roivant and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced the successful completion of enrollment in its Phase 2 study evaluating namilumab for...

at 08:05
Revvity, Inc. will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV. Senior Vice President and Chief Financial Officer Max Krakowiak will provide an update on the Company and its...



News published on and distributed by: